Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma
Clinical trial NCT06970145 · RECRUITING
Trial details
- NCT number
- NCT06970145
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-25
- Primary completion
- 2026-04-20
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.